These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17963324)

  • 21. Bone marrow natural suppressor cells inhibit the growth of myeloid progenitor cells and the synthesis of colony-stimulating factors.
    Moore SC; Theus SA; Barnett JB; Soderberg LS
    Exp Hematol; 1992 Nov; 20(10):1178-83. PubMed ID: 1426097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
    Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
    J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of acupuncture and moxibustion on serum contents of hematopoietic growth factor in mice with marrow inhibition].
    Lu M; Xiao T; Cao D; Zhang H; Li J; Wang G
    Zhongguo Zhen Jiu; 2015 Mar; 35(3):264-8. PubMed ID: 26062199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery.
    Maltby S; Hughes MR; Zbytnuik L; Paulson RF; McNagny KM
    Exp Hematol; 2009 Jan; 37(1):10-8. PubMed ID: 19004540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells.
    Sio A; Chehal MK; Tsai K; Fan X; Roberts ME; Nelson BH; Grembecka J; Cierpicki T; Krebs DL; Harder KW
    Cancer Res; 2013 Oct; 73(19):5892-904. PubMed ID: 23913828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echinacoside improves hematopoietic function in 5-FU-induced myelosuppression mice.
    Wang S; Zheng G; Tian S; Zhang Y; Shen L; Pak Y; Shen Y; Qian J
    Life Sci; 2015 Feb; 123():86-92. PubMed ID: 25623854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
    Hintz-Obertreis P; Weinmann E; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin augments granulocyte-macrophage colony-stimulating factor-induced hematopoiesis following 5-FU treatment.
    O'Reilly M; Gamelli RL
    Exp Hematol; 1990 Oct; 18(9):974-8. PubMed ID: 2204540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3.
    Migliaccio G; Migliaccio AR; Adamson JW
    Exp Hematol; 1991 Jan; 19(1):3-10. PubMed ID: 1989893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
    Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
    Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activity and effects of Colla corii asini on Salmonella typhimurium invasion in vitro and in vivo.
    Park KI; Lee MR; Oh TW; Kim KY; Ma JY
    BMC Complement Altern Med; 2017 Dec; 17(1):520. PubMed ID: 29202825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO; Schneider JG; Moore MA
    Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
    Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
    Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic growth factors in anemia of Belgrade laboratory (b/b) rats.
    Biljanović-Paunović L; Stojanović N; Mostarica-Stojković M; Ramić Z; Ivanović Z; Basara N; Clemons GK; Pavlović-Kentera V
    Exp Hematol; 1992 Dec; 20(11):1257-62. PubMed ID: 1493855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
    Kasper C; Zahner J; Sayer HG
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lisofylline inhibits transforming growth factor beta release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice.
    Clarke E; Rice GC; Weeks RS; Jenkins N; Nelson R; Bianco JA; Singer JW
    Cancer Res; 1996 Jan; 56(1):105-12. PubMed ID: 8548748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
    Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
    Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.